Article

Vitamins, if used correctly, may help prevent vision loss from AMD

A study conducted at Johns Hopkins University School of Medicine found that patients with age-related macular degeneration (AMD) appear to lack a clear understanding of supplement use in AMD treatment.

Balitmore-A study conducted at Johns Hopkins University School of Medicine found that patients with age-related macular degeneration (AMD) appear to lack a clear understanding of supplement use in AMD treatment, and that "improved patient education may be vital to maximize the potential" of this therapy, concluded researchers, led by Susan B. Bressler, MD.

It was found by researchers that nearly 40% of those likely to benefit from specific vitamin/mineral supplements either were not taking the supplements or not using the recommended dosage. Also, some patients used high-dose supplements even in the absence of evidence that these would be effective for their levels of AMD or other eye conditions.

The impact of these findings could be substantial because it is figured that in the United States if the appropriate patients used the correct supplements, about 300,000 people could potentially avoid advanced AMD within a 5-year period. A specific formula of antioxidants (vitamin C, vitamin E, and beta-carotene), found in 2001 by the Age-related Eye Disease Study, was able to reduce the probability of progression to advanced AMD by 25% among those at risk.

The Wilmer Eye Institute-based study surveyed 332 individuals who identified themselves as having AMD with the median participant age being 79 years old. Out of the 228 individuals who were considered candidates to benefit from the AREDS formula, only 140 patients were using the correct formula.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.